Organigram Global Inc. (OGI)
OGI Stock Price Chart
Explore Organigram Global Inc. interactive price chart. Choose custom timeframes to analyze OGI price movements and trends.
OGI Company Profile
Discover essential business fundamentals and corporate details for Organigram Global Inc. (OGI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
21 May 2019
Employees
1.14k
Website
https://www.organigram.caCEO
James H. Yamanaka
Description
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.
OGI Financial Timeline
Browse a chronological timeline of Organigram Global Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Dec 2026
EPS estimate is $0.00, while revenue estimate is $83.56m.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.01, while revenue estimate is $69.52m.
Earnings released on 12 May 2026
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $42.99m , missing expectations by -14.97%.
Earnings released on 10 Feb 2026
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%, while revenue for the quarter reached $46.27m , missing expectations by -13.14%.
Earnings released on 16 Dec 2025
EPS came in at -$0.20 falling short of the estimated -$0.00 by -4.06k%, while revenue for the quarter reached $57.40m , beating expectations by +13.65%.
Earnings released on 13 Aug 2025
EPS came in at -$0.03 falling short of the estimated -$0.01 by -200.00%, while revenue for the quarter reached $51.96m , missing expectations by -28.84%.
Earnings released on 12 May 2025
EPS came in at -$0.05 falling short of the estimated -$0.03 by -66.67%, while revenue for the quarter reached $46.06m , missing expectations by -29.47%.
Earnings released on 11 Feb 2025
EPS came in at -$0.05 falling short of the estimated -$0.03 by -66.67%, while revenue for the quarter reached $29.69m , missing expectations by -54.51%.
Earnings released on 18 Dec 2024
EPS came in at -$0.04 falling short of the estimated -$0.03 by -33.33%, while revenue for the quarter reached $33.09m , missing expectations by -36.60%.
Earnings released on 13 Aug 2024
EPS came in at $0.02 surpassing the estimated -$0.05 by +140.00%, while revenue for the quarter reached $30.03m , missing expectations by -6.85%.
Earnings released on 14 May 2024
EPS came in at -$0.12 falling short of the estimated -$0.06 by -100.00%, while revenue for the quarter reached $27.71m , missing expectations by -76.53%.
Earnings released on 13 Feb 2024
EPS came in at -$0.14 falling short of the estimated -$0.10 by -40.00%, while revenue for the quarter reached $27.45m , missing expectations by -1.97%.
Earnings released on 19 Dec 2023
EPS came in at -$0.04 surpassing the estimated -$0.14 by +71.43%, while revenue for the quarter reached $33.99m , beating expectations by +15.22%.
Earnings released on 13 Jul 2023
EPS came in at -$0.15 falling short of the estimated -$0.05 by -200.00%, while revenue for the quarter reached $24.29m , missing expectations by -15.17%.
Stock split effective on 7 Jul 2023
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Apr 2023
EPS came in at -$0.08 falling short of the estimated -$0.07 by -19.99%, while revenue for the quarter reached $29.01m , missing expectations by -9.93%.
Earnings released on 12 Jan 2023
EPS came in at -$0.04 falling short of the estimated -$0.01 by -184.90%, while revenue for the quarter reached $32.11m , missing expectations by -0.90%.
Earnings released on 28 Nov 2022
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $34.62m , beating expectations by +6.20%.
Earnings released on 14 Jul 2022
EPS came in at -$0.12 falling short of the estimated -$0.08 by -50.00%, while revenue for the quarter reached $30.23m , beating expectations by +13.40%.
Earnings released on 12 Apr 2022
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $25.03m , beating expectations by +0.21%.
Earnings released on 11 Jan 2022
EPS came in at -$0.12 falling short of the estimated -$0.07 by -79.99%, while revenue for the quarter reached $23.71m , beating expectations by +3.82%.
Earnings released on 23 Nov 2021
EPS came in at -$0.28 falling short of the estimated -$0.16 by -75.00%, while revenue for the quarter reached $19.78m , beating expectations by +6.67%.
OGI Stock Performance
Access detailed OGI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
